|
Prescribing
Information for BIPI Marketed Products |
|
|||||
|
Product Name |
Version |
Current Prescribing Information |
|
|||
|
|
||||||
|
Aggrenox®
Capsules
|
December 2019 |
|||||
|
Aptivus® Capsules and Oral
Solution |
November 2019 |
|||||
|
Atrovent® HFA Inhalation
Aerosol |
February
2020 IT7036C |
|||||
|
Catapres® Tablets |
August 2016 |
|||||
|
Catapres-TTS®
Transdermal Therapeutic System |
August 2016 |
|
||||
|
Combivent® Respimat®
|
June 2016 |
|
||||
|
Gilotrif® Tablets |
October 2019 |
|
||||
|
Glyxambi® Tablets |
March
2020 IT5885S |
|
||||
|
Jardiance® Tablets (empagliflozin) |
January 2020 IT5728V |
|
||||
|
Jentadueto® Tablets |
March
2020 IT6841I |
|
|
|||
|
Jentadueto® XR
extended-release tablets |
March
2020 IT6354H |
|
||||
|
Micardis® HCT Tablets |
February 2018 |
|
||||
|
Micardis® Tablets
|
February 2018 |
|
||||
|
Mirapex®
Tablets
|
April 2020 |
|
||||
|
Mirapex ER®
extended-release tablets
|
January 2020 |
|
|
|||
|
Mobic®
Tablets
|
February 2020 |
|
||||
|
Ofev® Capsules |
March 2020 |
|
||||
|
Persantine Tablets |
December 2019 |
|
||||
|
Pradaxa® Capsules (dabigatran etexilate mesylate) |
November 2019 |
|
||||
|
Praxbind® Injection |
April 2018 IT6116B |
|
||||
|
Spiriva® |
February 2018 |
|
||||
|
Spiriva® Respimat® |
March 2019 |
|
||||
|
Stiolto® Respimat® |
May 2019 |
|
||||
|
Striverdi®
Respimat® |
May 2019 |
|
||||
|
Synjardy® Tablets |
January 2020 |
|
||||
|
Synjardy® XR extended-release
Tablets |
January 2020 |
|
||||
|
Tradjenta® Tablets (linagliptin) |
March 2020 |
|
||||
|
Trijardy™ XR Tablets (empagliflozin, linagliptin, and metformin hydrochloride extended-release) |
January 2020 |
|
||||
|
Twynsta® Tablets |
February 2018 |
|
|
|||
|
Viramune® Tablets and Oral
Suspension |
October 2019 |
|
||||
|
Viramune XR®Tablets (nevirapine) |
October 2019 IT5243N |
|
||||
|
|
|
|
|
|||
|
|
||||||